HER2 status as well as expression of hormone receptors (HRs) (that is, estrogen receptor (ER) and progesterone receptor (PR)), are routinely determined in primary breast cancers, and metastatic lesions have typically been assumed to maintain the original phenotype. Here, ESR1 is linked to breast carcinoma.